Series B

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

Pittsburgh Life Sciences Greenhouse (PLSG) is a leading life sciences investment firm in Western Pennsylvania, dedicated to fostering innovation and commercialization in the life sciences sector. PLSG supports entrepreneurs and emerging companies by providing funding, strategic guidance, and access to resources, with a focus on improving healthcare outcomes and driving economic growth in the region. The firm is deeply connected to the growing impact of data analytics in healthcare and is committed to supporting underserved groups through initiatives like the 'Under 40, Underserved Advisory Board'.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.

KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

Brain Trust Accelerator Fund is a venture capital firm focused on impact investing in brain-related diseases. The firm specializes in translational stage investments that address the diagnosis and treatment of these diseases. With a strong track record, Fund I has generated top-tier returns, benefiting up to ten million patients and delivering significant charitable contributions. The firm leverages scientific advancements and market opportunities to invest in early-stage, translational research, aiming to transform pioneering research into meaningful clinical benefits.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Camino Real Capital Partners, LLC (CRCP) is a private investment firm based in Santa Fe, New Mexico, dedicated to investing in America's leading innovators and emerging technologies. The firm emphasizes building relationships, fostering growth opportunities, and creating value. CRCP focuses on transformative technology, emerging medical devices, life science innovations, and cutting-edge service providers in the energy sector. The firm invests its own capital alongside a network of accredited co-venturers, providing technology and marketing insights and management guidance to early-stage innovators.

Triangle Angel Partners (TAP) is an angel fund based in the Research Triangle Park area of North Carolina. Formed in 2011, TAP aims to leverage the expertise and capital of its members to support local entrepreneurs in high-tech start-ups. TAP provides not only financial investment but also mentoring, counseling, and access to a vast network of potential investors, customers, and strategic partners. The firm has launched two funds, TAP I and TAP II, with a focus on investing in companies within a half-day's drive of Research Triangle Park.

Black Diamond Ventures (BDV) is a transformational venture capital firm with over two decades of experience in hybrid investing. Founded by Chris Lucas, BDV focuses on multi-stage investments in biotech, deep tech, and med tech sectors, supporting visionary founders with strategic and operational guidance. The firm is committed to building relationships among investors and their investments, helping founders reach the next level through a network of partners and strategic opportunities.

Norwest Venture Partners is a multi-stage investment firm with a history of delivering top quartile returns over the past 60 years. The firm focuses on partnering with founder-managed or capital-efficient businesses, helping them scale from double-digit to triple-digit revenues. Norwest has navigated various economic cycles and remains committed to building strong relationships with its portfolio companies, emphasizing trust and cultural alignment.

LSG Investments is an evergreen venture fund dedicated to advancing healthcare by investing in early-stage life sciences technologies. The firm focuses on strengthening Pennsylvania's life sciences ecosystem and improving global healthcare outcomes. By providing early-stage capital and operational expertise, LSG Investments fosters company growth and job creation, bridging the gap between pre-seed and Series B funding.

Mercury Fund is an early-stage venture capital platform focused on transformative software startups across America. With a mission to drive exceptional outcomes for founders and investors, Mercury Fund emphasizes supporting underrepresented entrepreneurial communities. The firm has created over $9 billion in value through its operationally-focused investment strategy, partnering with both first-time and seasoned entrepreneurs to leverage growth networks and achieve sustainable growth.

NovaQuest Capital Management is a life science investment firm specializing in biopharmaceuticals, located in North Carolina’s Research Triangle. Founded in 2010, the firm focuses on promoting the late-stage development of life-saving drugs to reduce healthcare costs, address unmet medical needs, improve safety, and enhance quality of life. With a unique global platform, NovaQuest provides tailored capital solutions to fund innovation in biopharmaceutical development and invests in healthcare companies with products and technologies aimed at improving human and animal health.

Pandect Bioventures is a venture capital firm focused on providing seed to Series A and later funding to early-stage biotech and pharma companies. The firm leverages its extensive ecosystem, including a 40,000 square foot incubator facility, to support entrepreneurs in achieving critical business milestones. Pandect Bioventures is committed to identifying transformational healthcare ideas at the earliest stage and building them into successful life science companies through strategic partnerships, financial and technical support, and access to state-of-the-art research facilities.

NewSpring Capital is a private equity firm that partners with lower-middle market companies to create measurable value for business owners and Limited Partners. With over 25 years of experience, NewSpring focuses on fostering deep and enduring relationships, aligning goals and values with entrepreneurs, investors, and employees in pursuit of excellence. The firm manages over $3.5 billion across five distinct strategies, including growth equity, healthcare, mezzanine debt, holdings, and franchise investments. NewSpring is committed to accelerating growth and success for its portfolio companies through tailored capital solutions and strategic support.